Measuring Skin Damage in Systemic Sclerosis with a Skin Sensor
Part of Skin clinical trials.
This study tests a sensor device called ADHELASKIN to see if it can accurately measure skin damage in people with systemic sclerosis (SSc), a condition that hardens and tightens the skin. The goal is to find a better way to track skin changes during the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have systemic sclerosis (SSc), diagnosed using standard medical criteria.
- You are covered by French social security (or eligible for it).
- You have given written consent to join the study.
- You do not have other skin conditions that are inflamed or leave scars.
- You are not in custody or unable to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study uses skin samples from people with scleroderma, their relatives, and healthy volunteers to create stem cells in a lab. The goal is to learn more about the disease and find better ways to treat it.
This study uses a detailed look at your skin and scalp (often with a magnifying exam) to learn more about systemic scleroderma. It may help doctors understand the condition better and improve how it’s assessed over time.
This study looks at how a new drug affects skin scarring (fibrosis) in people with systemic sclerosis (SSc), a rare autoimmune disease. It aims to understand if this drug can help reduce the skin thickening and immune changes caused by SSc.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
Hear when a new D013493 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.